Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:38:13.194Z.
Calculation as of: 2026-10-06T19:38:13.194Z.
Quote observation: 2026-10-06T19:32:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5fded3d3484fa1cf7e618a907758d95a7a48bcc7542cb4bc7c8f037a45079178
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Silo Pharma, Inc.
Market Cap
$1.65M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.51M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.80M
Operating Cash Flow Yield
N/A
TTM Avg
1.39%
3Y Avg
1.39%
5Y Avg
1.39%
Market Cap
$1.83M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.48M
Operating Cash Flow Yield
N/A
TTM Avg
2.09%
3Y Avg
2.09%
5Y Avg
2.09%
Market Cap
$1.48M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.86M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.42M
Operating Cash Flow Yield
N/A
TTM Avg
13.05%
3Y Avg
13.05%
5Y Avg
13.05%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Silo Pharma, Inc. (SILO) | $1.65M | N/A | N/A | N/A | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.51M | N/A | N/A | N/A | N/A |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.80M | N/A | 1.39% | 1.39% | 1.39% |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.83M | N/A | N/A | N/A | N/A |
| Curis, Inc. (CRIS)vs › | $1.48M | N/A | 2.09% | 2.09% | 2.09% |
| PMGC Holdings Inc. (ELAB)vs › | $1.48M | N/A | N/A | N/A | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.45M | N/A | N/A | N/A | N/A |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.86M | N/A | N/A | N/A | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | N/A | 13.05% | 13.05% | 13.05% |
| Tenon Medical, Inc. (TNON)vs › | $1.89M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
